Latest media releases


UBS Global Life Sciences Conference Opens in New York

New York | | Media Releases Americas

The Tenth Annual UBS Global Life Sciences Conference begins today at the Grand Hyatt in New York City and continues through Thursday, September 25. The Conference will feature presentations by more than more than 300 public and private companies including biotechnology, medical device manufacturers, pharmaceuticals and specialty pharmaceutical companies.

The annual UBS Global Life Sciences Conference is among the largest health care investor conferences in the world. Senior executives from the leading pharmaceutical, biotechnology and medical technology companies will provide their insight and outlook on the global life sciences industry.


Actelion Pharmaceuticals Ltd.
Agilent Technologies
Alapis S.A.
Alexion Pharmaceuticals Inc
Amgen Inc.
Applied Biosystems Inc.
Biogen Idec
Boston Scientific Corporation
Bruker Corporation
Celgene Corporation
Cephalon Inc.
Charles River Laboratories
Covance Inc.
Dentsply International Inc.
Edwards Lifesciences
Eli Lilly & Co.
F. Hoffmann - La Roche Ltd.
Genentech, Inc.
Gen-Probe Inc.
Genzyme Corporation
Gilead Sciences, Inc.
Glenmark Pharmaceuticals Ltd.
Illumina, Inc.
Immucor Inc.
IMS Health Inc.
Intercell AG
Inverness Medical Innovations
Invitrogen Corporation
Laboratory Corporation of America
Lundbeck AS
MDS Inc.
Medtronic Inc.
Merck KGaA
Mettler Toledo International Inc.
Millipore Corporation
Myriad Genetics, Inc.
NBTY, Inc.
Nobel Biocare AB
Novartis AG
Onyx Pharmaceuticals, Inc.
OSI Pharmaceuticals, Inc.
Pall Corporation
PerkinElmer, Inc.
Pfizer Inc.
Qiagen NV
Quest Diagnostics
ResMed Inc.
Sepracor Inc
Shanghai Fosun Pharmaceutical (Group) Co. Ltd.
Sigma-Aldrich Corporation
Sonova Holding AG
Stericycle Inc.
Stryker
Synthes, Inc.
Teleflex Inc.
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific Corp
United Therapeutics Corporation
Vertex Pharmaceuticals Incorporated
Waters Corporation



*This is a partial list of presenting companies. Companies subject to change.

Online conference information
To access audio transmissions and the conference agenda please go to the UBS Investment Bank website at www.ibb.ubs.com. Audio transmissions of company presentations will be available live and by replay. Replays will begin three hours after the actual presentation time and will be available on the site for a period of four weeks.

UBS is one of the world's leading financial firms, serving a discerning international client base. UBS is a leading global wealth manager, a leading global investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking.

UBS is present in all major financial centers worldwide. It has offices in over 50 countries, with about 37% of its employees working in the Americas, 34% in Switzerland, 16% in the rest of Europe and 13% in Asia Pacific. UBS employs more than 80,000 people around the world. Its shares are listed on the Swiss Stock Exchange (SWX), the New York Stock Exchange (NYSE) and the Tokyo Stock Exchange (TSE).


Contact:

Laura Cora+1-212-882-6021

New York , September 22, 2008

UBS